These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38753540)

  • 1. Pituitary-related immune adverse events induced by programmed death Protein-1 inhibitors differ clinically from hypophysitis.
    Yang L; Zhang Y; Chen X; Liu K; Zhou Y; Wang S
    Clin Endocrinol (Oxf); 2024 Aug; 101(2):130-139. PubMed ID: 38753540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review.
    Wang F; Shi X; Yu X; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1326684. PubMed ID: 38318292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
    Kanie K; Iguchi G; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Ogawa W; Takahashi Y
    Cancer Immunol Immunother; 2021 Dec; 70(12):3669-3677. PubMed ID: 33977343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
    Johnson J; Goldner W; Abdallah D; Qiu F; Ganti AK; Kotwal A
    J Natl Compr Canc Netw; 2023 Feb; 21(3):281-287. PubMed ID: 36828029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors.
    Percik R; Shlomai G; Tirosh A; Tirosh A; Leibowitz-Amit R; Eshet Y; Greenberg G; Merlinsky A; Barhod E; Steinberg-Silman Y; Sella T
    Autoimmun Rev; 2020 Feb; 19(2):102454. PubMed ID: 31838158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors.
    Kobayashi T; Iwama S; Sugiyama D; Yasuda Y; Okuji T; Ito M; Ito S; Sugiyama M; Onoue T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Nishikawa H; Arima H
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitor-associated pituitary adverse events: an observational, retrospective, disproportionality study.
    Bai X; Chen X; Wu X; Huang Y; Zhuang Y; Chen Y; Feng C; Lin X
    J Endocrinol Invest; 2020 Oct; 43(10):1473-1483. PubMed ID: 32239475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
    Galligan A; Iravani A; Lasocki A; Wallace R; Weppler AM; Sachithanandan N; Chiang C; Colman PG; Wentworth J; Spain L; Au-Yeung G; Lee B; Kay TWH; Hicks RJ; Sandhu S; Krishnamurthy B
    Front Endocrinol (Lausanne); 2023; 14():1295865. PubMed ID: 38093958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune checkpoint inhibitors induced pituitary immune-related adverse events: diagnosis and management].
    Gu YC; Xie C; Cao BS
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1344-1351. PubMed ID: 36575785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of programmed cell death-1 inhibitor-associated hypophysitis].
    Zhang Y; Wang SC; Zhang Q; Li HY; Liu SS; Wang XH; Liu Y
    Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):192-197. PubMed ID: 38326046
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitors and Associated Pituitary Dysfunctions: A Mini-Review.
    Fukuda I
    J Nippon Med Sch; 2023 May; 90(2):149-156. PubMed ID: 36823122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases.
    Lupi I; Brancatella A; Cosottini M; Viola N; Lanzolla G; Sgrò D; Dalmazi GD; Latrofa F; Caturegli P; Marcocci C
    Endocrinol Diabetes Metab Case Rep; 2019 Oct; 2019():. PubMed ID: 31610523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S; Leiter A; Galsky M; Gallagher EJ
    J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.
    Iglesias P; Sánchez JC; Díez JJ
    Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.
    Kurokawa R; Ota Y; Gonoi W; Hagiwara A; Kurokawa M; Mori H; Maeda E; Amemiya S; Usui Y; Sato N; Nakata Y; Moritani T; Abe O
    AJNR Am J Neuroradiol; 2020 Sep; 41(9):1683-1689. PubMed ID: 32763900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review.
    Oğuz SH; Ünlütürk U; Aksoy S; Erbas T
    Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.
    Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M
    Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.